BioValley News

30.11.2011

Wechsel in der Direktion von Sanofi zum 1. Dezember

Mit Wirkung vom 1. Dezember 2011 wird Dr. Fabrizio Guidi zum neuen Country Manager von Sanofi in der Schweiz berufen. Dr. Fabrizio Guidi, Doktor der Biochemie (ETHZ) und seit zwölf Jahren für Sanofi tätig, tritt die Nachfolge von...[more]

28.11.2011

QIAGEN startet Initiative zur Steigerung der Effizienz und Verbesserung der Ressourcenallokation

Venlo, Niederlande, 28. November 2011 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) hat heute ein Projekt zur Steigerung der Produktivität gestartet. Hierfür sollen die Organisation gestrafft und Ressourcen...[more]

25.11.2011

mondoBIOTECH Holding AG (SIX: RARE) sets out to clarify some statements appearing in todays’ press

Stans, Switzerland, November 25, 2011 - Due to some unsubstantiated statements appearing in todays’ press, the company sets out to clarify that there is no delay in the access to the loan facility received from its largest...[more]

18.11.2011

Change in Visp Site Management

Basel, Switzerland 18 November 2011 – Lonza announces that Stefan Troger will be promoted to Site Manager of the Visp site, reporting to Harry Boot as of 1 April 2012. With this appointment leadership of the site and the Visp...[more]

14.11.2011

Midatech Receives Regulatory Approval to Start Phase I Trial of Diabetes Drug

Oxford, UK, 14 November 2011 – Midatech Group Ltd., a global leader in the design, development, synthesis and manufacture of nanomedicines, announced today it has received Swissmedic approval to start a First in Human clinical...[more]

9.09.2011

Keystone Mercy Health Plan, P4 Healthcare Help Community Oncologists Extend Quality Cancer Care to Underserved Populations in Pennsylvania

PHILADELPHIA and DUBLIN, Ohio - Keystone Mercy Health Plan and Cardinal Health Specialty Solutions' P4 Healthcare business announced the launch of an evidence-based program to improve cancer care for Medicaid patients in...[more]

9.09.2011

GE Healthcare’s Next Generation Nuclear Cardiology Platform Goes Mainstream

DENVER, Co. - GE Healthcare announced it has received commitments from more than 100 customers globally for its innovative Alcyone technology, a nuclear cardiology platform combining cadmium zinc telluride detectors, focused...[more]

9.09.2011

Abbott Named to the Dow Jones Sustainability Indexes for Seventh Consecutive Year in Recognition of Leading Corporate Citizenship Performance

Abbott Park, Illinois - Abbott announced that it was included on both the Dow Jones Sustainability World Index and North America Index for the seventh consecutive year.[more]

9.09.2011

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

RARITAN, N.J. - Johnson & Johnson Pharmaceutical Research and Development, L.L.C. announced that the U.S. Food and Drug Administration's Cardiovascular and Renal Drugs Advisory Committee recommended approval of rivaroxaban, a...[more]

9.09.2011

Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia

Abbott Park, Illinois - Abbott announced the initiation of ABSORB BTK, an international clinical trial evaluating the safety and efficacy of the ABSORB bioresorbable vascular scaffold (BVS) for the treatment of below-the-knee...[more]

Displaying results 1 to 10 out of 1768

1

2

3

4

5

6

7

8

9

10

Next >